Latest financial market updates and expert analysis
Earnings The disconnect has rarely been starker: Micron Technology just posted the best quarterly results in its corporate history, yet the stock is mired in its deepest drawdown of the year....
For nearly eight years, Alnylam has enjoyed something almost unheard of in biotech: a drug with no true rival for...
The numbers coming out of Cupertino last week were, by any conventional measure, exceptional. Revenue hit a record $109.4 billion...
A company that once promised investors hundreds of autonomous kitchen robots in the field by year-end is now targeting just...
The arithmetic of BioNTech’s share repurchase is straightforward on paper: a program of up to 24.9 million shares, capped at...
The tungsten producer’s journey toward a leaner exchange structure is nearly complete. Almonty Industries has now secured approval to delist...
The arithmetic is jarring. Micron Technology closed Friday at 714.70 euros, down 5.86 percent on the day and 21.71 percent...
The numbers tell a story of a company inching back from the edge. SAP’s shares closed Friday at €159.40, up...
The numbers tell a story of two very different timelines. On one hand, Vulcan Energy has just sealed the financial...
The options market is bracing for fireworks. When Novo Nordisk delivers its second-quarter results on August 5, derivatives pricing implies...
The countdown to AST SpaceMobile’s next orbital mission is drawing to a close, and the stakes extend well beyond the...
